Correlation Between Bristol Myers and Painreform

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Painreform at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Painreform into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Painreform, you can compare the effects of market volatilities on Bristol Myers and Painreform and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Painreform. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Painreform.

Diversification Opportunities for Bristol Myers and Painreform

-0.48

Correlation Coefficient

Bristol Myers  Painreform

Very good diversification

The 3 months correlation between Bristol and Painreform is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Painreform in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Painreform and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Painreform. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Painreform has no effect on the direction of Bristol Myers i.e., Bristol Myers and Painreform go up and down completely randomly.

Pair Corralation between Bristol Myers and Painreform

Considering the 90-day investment horizon Bristol Myers is expected to generate 1.62 times less return on investment than Painreform. But when comparing it to its historical volatility, Bristol Myers Squibb is 11.3 times less risky than Painreform. It trades about 0.15 of its potential returns per unit of risk. Painreform is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  535.00  in Painreform on August 30, 2024 and sell it today you would lose (260.00) from holding Painreform or give up 48.6% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Bristol Myers Squibb  vs.  Painreform

Bristol Myers Squibb

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.

Painreform

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Painreform are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical and fundamental indicators, Painreform showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bristol Myers and Painreform

The main advantage of trading using opposite Bristol Myers and Painreform positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Painreform can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Painreform will offset losses from the drop in Painreform's long position.

The idea behind Bristol Myers Squibb and Painreform pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.